0.00Open0.35Pre Close0 Volume30 Open Interest2.50Strike Price0.00Turnover313.27%IV27.52%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.35Extrinsic Value100Contract SizeAmericanOptions Type0.5125Delta0.3547Gamma6.39Leverage Ratio-0.0246Theta0.0002Rho3.27Eff Leverage0.0014Vega
Protara Therapeutics Stock Discussion
soon?
In a significant development for the biopharmaceutical industry, Protara Therapeutics, a company dedicated to identifying and advancing transformative therapies for rare and specialty diseases, announced an oversubscribed $45 million private placement financing. This milestone is no...
Chart watchers know that means bulls are losing their control, and the trend may reverse.
Meanwhile, technical indicators are suggesting movement biased to the Neutral < Buy territory.
Here's a little tidbit about TARA:
TARA IS A LONG HOLD. FORECASTING Q2 CATALYSTS WILL SEND THIS INTO DOUBLE DIGITS! BUY LOW, SELL HIGH!
No comment yet